Jaypirca(Pirtobrutinib) Side Effects

Common and serious adverse reactions associated with the drug.

Adverse Reactions

The most frequently reported adverse reactions (≥20%) include fatigue, musculoskeletal pain, diarrhea, COVID-19, bruising, and cough. Clinically significant serious reactions encompass infections (including fatal cases of pneumonia and sepsis), hemorrhage, cytopenias, cardiac arrhythmias (such as atrial fibrillation), the development of second primary malignancies, and hepatotoxicity. Grade 3 or 4 laboratory abnormalities commonly include decreased neutrophil count, decreased platelet count, decreased hemoglobin, and decreased lymphocyte count.

Related Columns

Pirtobrutinib(Jaypirca)

Treatment of relapsed or refractory mantle cell lymphoma (MCL) and chronic...

WeChat Scan
Free Inquiry

Side Effects of Pirtobrutinib

Pirtobrutinib is a novel Bruton’s Tyrosine Kinase (BTK) inhibitor. It has been approved for the treatment of relapsed/refractory mantle cell lymphoma (MCL) in patients who have received at least 2 lin...

Side effects of Pirtobrutinib

Pirtobrutinib is a kinase inhibitor. Like most powerful drugs, the use of Pirtobrutinib is accompanied by a series of potential side effects. This article will explore the side effects, miti...